BRCA1 and breast cancer: Most of the 31 patients with a BRCA1 pathogenic/likely-pathogenic mutation had BC: 23 (74.2%) had initial BC, 6 (26.1%) of whom BBC, and 1 (4.3%) subsequent OC.